Some researchers propose maternal Alzheimer disease (AD) inheritance. We compared dementia family histories in AD cases and cognitively normal controls. We expected more mothers to have AD in both groups. If maternal risk was not only due to female longevity, more AD cases' than controls' mothers should have dementia. We matched 196 AD cases to 200 controls by sex and age. We obtained parent dementia status and age of death for 348 AD and 319 control parents. Twenty-four (12%) controls' fathers, 26 (13%) AD patients' fathers, 58 (29%) controls' mothers, and 55 (28%) AD mothers had memory difficulty. More mothers than fathers had memory problems in both groups and the statistical significance persisted after adjusting for parent age at death and APOE for controls [odds ratios (OR) = 2.40, P = 0.004] but not cases (OR = 1.63, P = 0.14), although the results are qualitatively similar. There was no evidence of a real difference between the 2 groups in interaction analysis (P = 0.41). Mothers of both cases and controls were more often affected than fathers, even after adjusting for age. Cases' mothers no more often had dementia than controls' mothers, which does not support maternal AD transmission. Rather, the increased number of affected mothers relates, at least in part, to female longevity.
O ther than advanced age, having a family history of Alzheimer disease (AD) is the biggest risk factor for developing this disease. On the basis of twin studies, 60% to 80% of AD risk is genetic. 1 Some studies estimate that the E4 allele of the APOE gene may account for up to 25% 2 and variants of additional genes such as Clu, PICALM, and BIN1 are currently being investigated as late-onset genetic risk factors http://www.alzgene.org/. Yet, much of the genetic risk remains unexplained.
More women are affected with AD than men 3 and in 1 study of parents of affected individuals, the age-adjusted maternal to paternal relative risk was estimated at 2.8 [95% confidence interval (CI), 1.1-7.7]. 4 To explain these findings, researchers have explored the genetic mechanisms thought to be related specifically to maternal AD transmission. These include epigenetic imprinting, chromosome X mutations, and mitochondrial DNA-mediated transmission. The studies investigating these mechanisms have not yet yielded conclusive results. 5 Brain imaging studies have provided potential support for AD maternal transmission. Mosconi et al 6 found greater brain glucose metabolism reduction and Honea et al 7 found increased atrophy of AD-sensitive areas in cognitively normal subjects with a maternal history of AD. Andrawis et al 8 reported, in the Alzheimer Neuroimaging Initiative sample, that mild cognitive impairment and AD patients with AD maternal history had smaller hippocampi at baseline and greater atrophy at follow-up.
Family history studies investigating maternal AD transmission have yielded mixed results. Edland et al 4 found that dementia patients' mothers have a higher ageadjusted risk of Primary Progressive Dementia than fathers. Ehrenkrantz et al 9 found conflicting evidence that AD patients' mothers are not more likely than fathers to have dementia or have affected offspring. We found no studies that directly compared AD probands' family histories with those of cognitively normal controls matched by sex and age strata.
The present study compared parental dementia frequency in AD cases and cognitively normal controls matched by sex and age strata. We obtained family history data using patient information forms and medical record review. We expected that both cases and controls would have more mothers who had been affected with dementia than fathers. The goal of this study was to further investigate the maternal transmission hypothesis. If it is correct, then we would expect, after adjusting for parent age, a higher odds ratio (OR) for maternal to paternal dementia among parents of AD cases than for parents of controls.
METHODS
A total of 200 AD cases were identified along with 200 controls frequency matched by sex and 5-year age strata. The controls were from a longitudinal biomarker study. Volunteers undergo initial neurological and neuropsychological examination and are then seen annually with neuropsychology testing. None were spouses of the patients and were not related to the patients. Four of the AD patients were subsequently excluded because their data were unavailable. With family history forms and medical record review, dementia status and age of death were obtained for as many of the parents as was possible. Although all parents were deceased at the time of the study, father's age of death was unknown for 29 controls and 16 cases and mother's age of death was unknown for 37 controls and 16 cases. Numerical variables were summarized with the sample median, interquartile range, minimum, and maximum. Categorical variables were summarized with the number and percent. Comparisons of patient characteristics and family history of memory problems between cases and controls were performed using either a Wilcoxon rank-sum test (numerical variables) or Fisher exact test (categorical variables). Separately for parents of AD cases and parents of controls, single variable and multivariable logistic regression models fit by generalized estimating equations to account for the correlation among parents of each case or control were used to examine associations of patient and parent characteristics with memory problems in parents. Estimated ORs and the corresponding 95% CIs were computed. Further logistic regression models were used to investigate interactions. P values < 0.05 were considered statistically significant. Statistical analyses were performed using SAS (version 9.2; SAS Institute Inc., Cary, NC).
RESULTS
The characteristics of AD cases and controls are summarized in Table 1 . For both cases and controls, the median age was 79 years and 35% were men. Compared with controls, cases had a higher prevalence of APOE E4 (64% vs. 27%, P < 0.001). No other statistically significant differences between cases and controls were observed, although, not surprisingly, the median ages at death of mothers were greater than those of fathers for both cases and controls.
Associations of patient and parent characteristics with dementia of parents are summarized in Table 2 for the 348 parents of AD cases and 319 parents of controls for whom data were complete with respect to age at death, dementia status, and APOE genotype of offspring. In single variable analysis, there was evidence that mothers are more likely to have been reported to have a history of dementia compared with fathers for both cases (OR = 2.33, P = 0.004) and controls (OR = 2.96, P < 0.001) and parents who live longer are more likely to have dementia for both cases [OR (10-y increase) = 1.98, P < 0.001] and controls [OR (10-y increase) = 2.01, P < 0.001]. Although not statistically significant, the data were consistent with an increase in the odds of dementia in the parent when the child had APOE E4; this was more apparent in parents of controls than cases (OR = 1.78, P = 0.054).
The statistical significance of the association between parent sex and dementia persisted after adjusting for parent age at death and APOE E4 for controls (OR = 2.40, 95% CI: 1.32-4.38, P = 0.004) but not cases (OR = 1.63, 95% CI: 0.87-3.05, P = 0.14), although the results are qualitatively similar. Analysis of interactions yielded no evidence of differences between cases and controls with respect to whether their mothers had more memory problems than 8An additional model adjusting for parent sex does not provide statistically significant evidence that parents of controls live longer than cases (P = 0.10). AD indicates Alzheimer disease; NA, not available. zIn an additional multivariable model that incorporated both parents of AD cases and parents of controls, with an interaction term between parent's sex and AD status of "child," there was no evidence of a difference in the maternal versus paternal effect in parents of AD cases versus controls (P = 0.52). AD indicates Alzheimer disease; CI, confidence interval; OR, odds ratios. 
DISCUSSION
Mothers of both cases and controls lived longer than fathers and even after adjusting for age at death were more than twice as likely to have memory difficulties reported. This is consistent with previous research. 3, 4 However, cases' mothers no more often had dementia than controls' mothers. After adjusting for APOE E4 and parent age, there was statistically significant evidence that the risk of dementia for controls' mothers was higher than that for fathers; the same relationship was apparent for AD cases, although to a lesser degree that was not statistically significant in this study.
Using a very large sample size and controlling for age structure and longevity, Ehrenkrantz et al 9 also found no evidence for increased maternal AD transmission. Unexpectedly, they estimated the cumulative risk of Primary Progressive Dementia to be higher in offspring of affected fathers than those with affected mothers.
Despite the findings of this study, there is a body of evidence that could support the maternal transmission of AD. Functional and structural imaging studies have shown that AD cases and cognitively normal controls with a maternal AD history have increased brain atrophy of ADsensitive areas and increased glucose hypometabolism compared with subjects with either no AD parental history or a paternal history. [6] [7] [8] This could also indicate that a maternal AD history may influence earlier onset and rate of progression but not necessarily implicate a special role of maternal transmission in disease etiology. Prospective longitudinal studies may help resolve this issue.
Edland et al 4 investigated maternal AD transmission using cognitively normal spouses as the primary source of family history information and as controls. The ageadjusted relative risk of dementia was nearly 3 times higher for cases' mothers than fathers. They also found an increased risk in the control spouse mothers that was not significant but they pointed out that there were only 14 affected parents (10 mothers and 4 fathers) and suggested a larger study.
One of the limitations of the present study includes not evaluating separately early-onset Alzheimer disease (EOAD) and late-onset Alzheimer disease (LOAD). EOAD and LOAD are thought to be mediated by different genetic mechanisms. If the relationship between AD maternal/paternal transmission was examined separately for EOAD and LOAD, maternal AD transmission may be more prominent in one or the other. Another limitation was the reliance on cases and controls' medical records for parental information. The data were not always complete and parent dementia status was based on family members' recollections rather than a formal diagnosis. Recall bias could have occurred. Without the assistance of caregivers, demented patients may be less able to recall parental dementia status. Conversely, controls less often retrospectively view parental memory difficulties as significant. Men in the parental generation may also be less likely to report cognitive decline than women. It is possible that men in the parental generation had more education and thus may have benefited from a greater cognitive reserve. There is evidence suggesting that men with dementia have greater reduction in cerebral metabolism than in women who have dementia 10 and is in keeping with the hypothesis of higher cognitive reserve in the men. Similarly, Barnes et al 11 found greater clinical dementia expression in women compared with men with comparable AD pathology.
The results of the present study do not support maternal AD transmission. Other approaches to this issue still raise the possibility that increased maternal transmission is plausible. Future studies should include prospective longitudinal determination of AD transmission, rate of progression, and evaluation of early-onset and late-onset AD. In this way, the apparently conflicting findings may be explained.
